Acute	O
ablation	O
of	O
Langerhans	B-Cell
cells	I-Cell
enhances	O
skin	B-Organ
immune	O
responses	O
.	O

Understanding	O
the	O
function	O
of	O
Langerhans	B-Cell
cells	I-Cell
(	O
LCs	B-Cell
)	O
in	O
vivo	O
has	O
been	O
complicated	O
by	O
conflicting	O
results	O
from	O
LC	B-Cell
-	O
deficient	O
mice	O
.	O

Human	O
Langerin	O
-	O
DTA	O
mice	O
constitutively	O
lack	O
LCs	B-Cell
and	O
develop	O
exaggerated	O
contact	O
hypersensitivity	O
(	O
CHS	O
)	O
responses	O
.	O

Murine	O
Langerin	O
-	O
diphtheria	O
toxin	O
receptor	O
(	O
DTR	O
)	O
mice	O
allow	O
for	O
the	O
inducible	O
elimination	O
of	O
LCs	B-Cell
and	O
Langerin	B-Cell
(	I-Cell
+	I-Cell
)	I-Cell
dermal	I-Cell
dendritic	I-Cell
cells	I-Cell
(	O
dDCs	B-Cell
)	O
after	O
administration	O
of	O
diphtheria	O
toxin	O
,	O
which	O
results	O
in	O
reduced	O
CHS	O
.	O

When	O
Langerin	B-Cell
(	I-Cell
+	I-Cell
)	I-Cell
dDCs	I-Cell
have	O
partially	O
repopulated	O
the	O
skin	B-Organ
but	O
LCs	B-Cell
are	O
still	O
absent	O
,	O
CHS	O
returns	O
to	O
normal	O
.	O

Thus	O
,	O
LCs	B-Cell
appear	O
to	O
be	O
suppressive	O
in	O
human	O
Langerin	O
-	O
DTA	O
mice	O
and	O
redundant	O
in	O
murine	O
Langerin	O
-	O
DTR	O
mice	O
.	O

To	O
determine	O
whether	O
inducible	O
versus	O
constitutive	O
LC	B-Cell
ablation	O
explains	O
these	O
results	O
,	O
we	O
engineered	O
human	O
Langerin	O
-	O
DTR	O
mice	O
in	O
which	O
diphtheria	O
toxin	O
ablates	O
LCs	B-Cell
without	O
affecting	O
Langerin	B-Cell
(	I-Cell
+	I-Cell
)	I-Cell
dDCs	I-Cell
.	O

The	O
inducible	O
ablation	O
of	O
LCs	B-Cell
in	O
human	O
Langerin	O
-	O
DTR	O
mice	O
resulted	O
in	O
increased	O
CHS	O
.	O

Thus	O
,	O
LC	B-Cell
-	O
mediated	O
suppression	O
does	O
not	O
require	O
their	O
absence	O
during	O
ontogeny	O
or	O
during	O
the	O
steady	O
-	O
state	O
and	O
is	O
consistent	O
with	O
a	O
model	O
in	O
which	O
LCs	B-Cell
actively	O
suppress	O
Ag	O
-	O
specific	O
CHS	O
responses	O
.	O

